What are the dos and don'ts of the Human Papillomavirus (HPV) vaccine, and how effective is it?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HPV Vaccination: Dos, Don'ts, and Efficacy

The HPV vaccine is highly effective and should be routinely administered to all children aged 11-12 years (can start as early as age 9), with catch-up vaccination recommended through age 26 years for those not previously vaccinated. 1

Vaccination Schedule

Dos:

  • Administer HPV vaccine according to age-appropriate schedules:
    • Ages 9-14 years: 2-dose schedule (0,6-12 months)
    • Ages 15-26 years: 3-dose schedule (0,1-2,6 months) 2, 1
  • Prioritize vaccination before sexual debut for maximum effectiveness 2, 1
  • Provide catch-up vaccination for all unvaccinated individuals through age 26 2
  • Consider shared decision-making for adults aged 27-45 who may benefit from vaccination 2
  • Administer HPV vaccine at the same visit as other age-appropriate vaccines 2

Don'ts:

  • Don't delay vaccination until sexual activity begins 2, 1
  • Don't administer during pregnancy (postpone until after pregnancy) 2
  • Don't skip cervical cancer screening after vaccination 2, 1
  • Don't require HPV testing or Pap tests before vaccination 2
  • Don't assume vaccination is ineffective for sexually active individuals (they may still benefit from protection against HPV types they haven't been exposed to) 2

Efficacy

The HPV vaccine demonstrates excellent efficacy when administered before exposure to HPV:

  • Prevents 70% of cervical cancers (HPV types 16/18) 2
  • Prevents 90% of genital warts (HPV types 6/11) 2
  • Prevents anal HPV infection and anal intraepithelial neoplasia with 77.5% efficacy 1, 3
  • Highly immunogenic with highest antibody responses in ages 9-15 years 2
  • Provides protection for at least 5 years without evidence of waning protection 2
  • Reduces HPV prevalence in vaccinated populations, showing real-world effectiveness 3, 4

Special Populations

Immunocompromised Individuals:

  • Require 3-dose schedule regardless of age 1
  • Can safely receive the vaccine 2

Individuals with Abnormal Pap Tests:

  • Can still receive HPV vaccination 2
  • Should continue with recommended cervical cancer screening 2, 1

Breastfeeding Women:

  • Can safely receive HPV vaccination 2

Common Pitfalls to Avoid

  1. Delaying vaccination until sexual debut: Maximum benefit occurs when administered before any HPV exposure 2, 1

  2. Assuming no benefit for sexually active individuals: Most sexually active people have not been exposed to all vaccine HPV types and can still benefit from vaccination 2

  3. Discontinuing cervical cancer screening after vaccination: The vaccine does not protect against all HPV types that cause cervical cancer, so screening must continue 2, 1

  4. Administering incorrect dosing schedule: Follow the 2-dose schedule for ages 9-14 and 3-dose schedule for ages 15+ 2, 1

  5. Missing minimum intervals between doses: Minimum interval is 4 weeks between doses 1 and 2, and 12 weeks between doses 2 and 3 2

The current 9-valent HPV vaccine (Gardasil 9) protects against nine HPV types (6,11,16,18,31,33,45,52, and 58), providing broader coverage than earlier vaccine formulations 5, 3.

References

Guideline

HPV Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Population impact of HPV vaccines: summary of early evidence.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.